We are live on ! Find out more
Legal & General Group

Legal & General Group Portfolio holdings

AUM $432B
1-Year Est. Return 29.4%
 

Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.

This Quarter Est. Return
+23.27%
1 Year Est. Return
+29.4%
3 Year Est. Return
+97.7%
5 Year Est. Return
+129.51%
10 Year Est. Return
+472.83%
AUM
$207B
AUM Growth
+$35.9B
Cap. Flow
+$1.78B
Cap. Flow %
0.86%
Top 10 Hldgs %
21.17%
Holding
3,579
New
222
Increased
1,974
Reduced
815
Closed
175

Top Buys

Rank Stock Value
1
TT icon
Trane Technologies
TT
+$169M
2
ABBV icon
AbbVie
ABBV
+$155M
3
OTIS icon
Otis Worldwide
OTIS
+$127M
4
BLK icon
Blackrock
BLK
+$110M
5
BABA icon
Alibaba
BABA
+$109M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$372M
2
RTN
Raytheon Company
RTN
+$235M
3
AAPL icon
Apple
AAPL
+$143M
4
MSFT icon
Microsoft
MSFT
+$90.5M
5
MCD icon
McDonald's
MCD
+$56.1M

Sector Composition

Rank Sector Weight
1 Technology 22.87%
2 Healthcare 13.29%
3 Financials 12.68%
4 Consumer Discretionary 11.36%
5 Communication Services 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDSI
2601
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$77K ﹤0.01%
17,616
+1,445
+9% +$6.49K
TBBK icon
2602
The Bancorp
TBBK
$2.84B
$76K ﹤0.01%
7,753
VALE icon
2603
Vale
VALE
$62.6B
$76K ﹤0.01%
7,384
HTB
2604
HomeTrust Bancshares
HTB
$848M
$76K ﹤0.01%
4,762
-187
-4% -$2.81K
FBMS
2605
DELISTED
The First Bancshares, Inc.
FBMS
$76K ﹤0.01%
3,365
+459
+16% +$9.33K
EVRI
2606
DELISTED
Everi Holdings
EVRI
$75K ﹤0.01%
14,622
-1,727
-11% -$8.77K
WTBA icon
2607
West Bancorporation
WTBA
$485M
$75K ﹤0.01%
4,308
NGM
2608
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$75K ﹤0.01%
3,794
+45
+1% +$860
CPLG
2609
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
$75K ﹤0.01%
17,893
-1,187
-6% -$4.64K
IIIV icon
2610
i3 Verticals
IIIV
$342M
$74K ﹤0.01%
2,456
+58
+2% +$1.47K
CIA icon
2611
Citizens
CIA
$192M
$73K ﹤0.01%
12,191
FISI icon
2612
Financial Institutions
FISI
$821M
$73K ﹤0.01%
3,926
SYRS
2613
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$73K ﹤0.01%
684
+113
+20% +$10.1K
BCEL
2614
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$73K ﹤0.01%
3,452
+794
+30% +$14K
CTMX icon
2615
CytomX Therapeutics
CTMX
$754M
$72K ﹤0.01%
8,662
+389
+5% +$3.61K
FRPH icon
2616
FRP Holdings
FRPH
$421M
$72K ﹤0.01%
3,578
-534
-13% -$11.1K
PASG icon
2617
Passage Bio
PASG
$14.1M
$72K ﹤0.01%
+132
New +$59.4K
TRC icon
2618
Tejon Ranch
TRC
$451M
$72K ﹤0.01%
5,023
VKTX icon
2619
Viking Therapeutics
VKTX
$4B
$72K ﹤0.01%
9,956
+594
+6% +$3.94K
VMD icon
2620
Viemed Healthcare
VMD
$371M
$72K ﹤0.01%
+7,592
New +$59K
AMTB icon
2621
Amerant Bancorp
AMTB
$1.13B
$71K ﹤0.01%
4,721
+2,378
+101% +$32.1K
OCUL icon
2622
Ocular Therapeutix
OCUL
$2.02B
$70K ﹤0.01%
8,454
+1,649
+24% +$10.9K
OLP
2623
One Liberty Properties
OLP
$527M
$70K ﹤0.01%
3,966
REPL icon
2624
Replimune Group
REPL
$1.01B
$70K ﹤0.01%
2,835
+680
+32% +$12K
VSEC icon
2625
VSE Corp
VSEC
$6.12B
$70K ﹤0.01%
2,235
-598
-21% -$13.6K

Similar funds

Legal & General Group's Q2 2020 Portfolio in Review

As of Q2 2020, Legal & General Group held 3,579 positions worth $207B, up 21% from $171B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Legal & General Group's Q2 2020 filing shows 222 new, 1,974 increased, 815 reduced and 175 closed positions. Its largest new stake was Otis Worldwide: 2,441,915 shares worth $139M. The largest sale was Allergan plc, an estimated $372M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Legal & General Group's largest Q2 2020 buy was Otis Worldwide: 2,441,915 shares worth $139M.
  • Legal & General Group added most to Trane Technologies in Q2 2020, an estimated $169M increase.
  • Legal & General Group's biggest Q2 2020 reduction was Apple, cutting an estimated $143M.
  • Legal & General Group fully exited Allergan plc in Q2 2020, selling an estimated $372M.
  • Legal & General Group's ten largest holdings make up 21% of its $207B portfolio in Q2 2020.
  • Legal & General Group opened 222 new positions and closed 175 in Q2 2020.
  • Legal & General Group's portfolio value rose 21% quarter-over-quarter to $207B.

Based on Legal & General Group's 13F filing for Q2 2020, filed 14 Aug 2020.